Autogenic splenic implantation in distal pancreatectomy with splenectomy for benign lesions of the distal pancreas

niversity Hospital Southampton NHS Foundation Trust0 个研究点目标入组 55 人开始时间: 2019年2月18日最近更新: 2024年1月22日

试验速览

2024 Protocol article in https://pubmed.ncbi.nlm.nih.gov/38195501/ (added 10/01/2024)

•Current inclusion criteria as of 08/06/2022:
•2. Indication for distal pancreatectomy for suspected benign lesion
•3. Either spleen-preserving or with splenectomy
•4. Either laparoscopic or robotic procedures
•5. Fit to undergo distal pancreatectomy (American Society of Anaesthesiologists classification of 3 or below)
•Previous inclusion criteria:
•2. Indication for distal pancreatectomy for suspected benign lesion
•3. Either spleen-preserving or with splenectomy
•4. Either open or laparoscopic
•5. Fit to undergo distal pancreatectomy (American Society of Anaesthesiologists classification of 3 or below)

•1. Proven or suspected malignant lesion of the pancreatic body or tail
•2. Asplenia, either functional, surgical or congenital
•3. Any other known immune deficiency disorder
•4. Known allergy to any of the Typhim Vi vaccine containing components
•5. Pregnancy
•6. Unfit to undergo distal pancreatectomy (American Society of Anaesthesiologist classification above 3)
•7. Prisoners and adults lacking capacity to consent

发起方

niversity Hospital Southampton NHS Foundation Trust